Stock Events

Stock Events

Charles River Laboratories International 

€234.00
96
-€3.90-1.64% Thursday 19:46

Statistics

Day High
238.7
Day Low
233.1
52W High
259.4
52W Low
124.05
Volume
-
Avg. Volume
-
Mkt Cap
11.17B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Dec 996
€0.08
Dec 996
€0.08
Nov 996
€0.08
Nov 996
€0.08
Nov 996
€0.08
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

11NovExpected
Q4 2025
Q1 2026
Q2 2026
Next
1.66
1.98
2.29
2.61
Expected EPS
2.5458794399999998
Actual EPS
N/A

Financials

-3.45%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.49BRevenue
-120.28MNet Income

Analyst Ratings

203.68Average Price Target
The highest estimate is 235.23.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
71%
Hold
29%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RV6.STU. It's not an investment recommendation.
Microsoft
32
MSFT
Apple
26
AAPL
Amazon
26
AMZN
NVIDIA
26
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
IQVIA
IQV
Mkt Cap44.07B
IQVIA provides similar contract research services, including preclinical and clinical trials, making it a direct competitor.
Icon Energy
ICON
Mkt Cap3.31M
ICON plc offers clinical research services, making it a competitor in the pharmaceutical and biotechnology development sector.
Wuxi AppTec.
WUXAY
Mkt Cap60.27B
WuXi AppTec provides a broad range of R&D and manufacturing services, competing in pharmaceutical, biotech, and medical device R&D.
Medpace
MEDP
Mkt Cap16.5B
Medpace Holdings, Inc. specializes in clinical research services, directly competing with CRL in the CRO market.
Illumina
ILMN
Mkt Cap32.95B
Illumina, Inc. provides genomics and sequencing services, indirectly competing by offering critical technologies for biopharmaceutical research.

About

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Show more...
CEO
Birgit Girshick
Employees
19700
Country
United States
ISIN
US1598641074
WKN
000939391

Listings

LSE
GB
0ADA.LSE
STU
DE
RV6.STU
MU
DE
RV6.MU
F
DE
RV6.F

0 Comments

Share your thoughts

FAQ

What is Charles River Laboratories International stock price today?▼
The current price of RV6.STU is €234.00 EUR — it has decreased by -1.64% in the past 24 hours. Watch Charles River Laboratories International stock price performance more closely on the chart.
What is Charles River Laboratories International stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Charles River Laboratories International stocks are traded under the ticker RV6.STU.
Is Charles River Laboratories International stock price growing?▼
RV6.STU stock has fallen by -5.68% compared to the previous week, the month change is a -3.78% fall, over the last year Charles River Laboratories International has showed a +79.38% increase.
What is Charles River Laboratories International market cap?▼
Today Charles River Laboratories International has the market capitalization of 11.17B
When is the next Charles River Laboratories International earnings date?▼
Charles River Laboratories International is going to release the next earnings report on November 11, 2026.
What were Charles River Laboratories International earnings last quarter?▼
RV6.STU earnings for the last quarter are 2.61 EUR per share, whereas the estimation was 2.37 EUR resulting in a +10.14% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Charles River Laboratories International revenue for the last year?▼
Charles River Laboratories International revenue for the last year amounts to 3.49B EUR.
What is Charles River Laboratories International net income for the last year?▼
RV6.STU net income for the last year is -120.28M EUR.
Does Charles River Laboratories International pay dividends?▼
Yes, RV6.STU dividends are paid monthly. The last dividend per share was 0.08 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Charles River Laboratories International have?▼
As of September 11, 2026, the company has 19,700 employees.
In which sector is Charles River Laboratories International located?▼
Charles River Laboratories International operates in the Health & Wellness sector.
When did Charles River Laboratories International complete a stock split?▼
Charles River Laboratories International has not had any recent stock splits.
Where is Charles River Laboratories International headquartered?▼
Charles River Laboratories International is headquartered in WILMINGTON, United States.